XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021   0 115,277      
Beginning balance at Dec. 31, 2021 $ 360,528 $ 0 $ 115 $ 1,040,098 $ (679,595) $ (90)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plans (in shares)     697      
Issuance of common stock under employee stock compensation plans 2,080   $ 1 2,079    
Share-based compensation 5,386     5,386    
Net loss (34,536)       (34,536)  
Unrealized loss on available for sale securities, net of tax (304)         (304)
Balance at end of period (in shares) at Mar. 31, 2022   0 115,974      
Ending balance at Mar. 31, 2022 333,154 $ 0 $ 116 1,047,563 (714,131) (394)
Balance at beginning of period (in shares) at Dec. 31, 2022   0 136,640      
Beginning balance at Dec. 31, 2022 534,657 $ 0 $ 137 1,399,555 (864,806) (229)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plans (in shares)     610      
Issuance of common stock under employee stock compensation plans 2,589     2,589    
Share-based compensation 11,899     11,899    
Net loss (72,229)       (72,229)  
Unrealized loss on available for sale securities, net of tax 130         130
Balance at end of period (in shares) at Mar. 31, 2023   0 137,250      
Ending balance at Mar. 31, 2023 $ 477,046 $ 0 $ 137 $ 1,414,043 $ (937,035) $ (99)